Buy Premium DYRK1A Inhibitor for Research – 99.9% Purity, GMP-Certified, Fast US Delivery from China

As a purchasing manager or technical director in biotech or pharma R&D, you face high costs, inconsistent quality, and delays in sourcing reliable DYRK1A inhibitors for Alzheimer's, Down syndrome, or neuroscience studies. Global Technology Co., Ltd delivers lab-grade DYRK1A inhibitor at 30% below market prices, with full traceability and 24-48 hour quotes.

Understanding DYRK1A Inhibitor: The Key to Breakthroughs in Neurodegenerative Research

DYRK1A (Dual-specificity Tyrosine Phosphorylation-Regulated Kinase 1A) is a serine/threonine kinase encoded by the DYRK1A gene on human chromosome 21. As a purchasing manager in the USA biotech sector, you're likely sourcing DYRK1A inhibitors for critical applications in Alzheimer's disease modeling, Down syndrome therapeutics, and autism spectrum disorder studies. These inhibitors modulate DYRK1A activity, which is overexpressed in Down syndrome and implicated in tau hyperphosphorylation in Alzheimer's.

First identified in 1996, DYRK1A belongs to the CK1/DYRK kinase family. It plays pivotal roles in neuronal development, synaptic plasticity, and cell cycle regulation. Overexpression leads to cognitive impairments, making selective DYRK1A inhibitors essential for research. Common inhibitors include Harmine (a natural beta-carboline alkaloid from Banisteriopsis caapi), INDY (N-[2-(1H-indol-3-yl)ethyl]-2-[1-(pyridin-2-ylmethyl)piperidin-4-yl]acetamide), and novel ATP-competitive compounds like AZD-7762 derivatives.

In your lab, a high-purity DYRK1A inhibitor enables precise dose-response curves, IC50 values typically ranging from 10-500 nM. For instance, Harmine exhibits IC50 ~30 nM against DYRK1A while sparing CLK1/2 at higher concentrations. This selectivity is crucial for dissecting DYRK1A's role in Tau pathology—studies in Nature Neuroscience (2020) show DYRK1A inhibition reduces insoluble Tau by 40% in mouse models.

Market demand surges with NIH funding: US grants for DYRK-related research exceeded $150M in 2025. Yet, supply chains falter. Traditional suppliers charge $500-2000/g for 98% purity, with lead times of 4-6 weeks. Chinese competitors undercut on price but compromise on GMP compliance and CoA authenticity.

Global Technology Co., Ltd bridges this gap. Our DYRK1A inhibitor (CAS: proprietary analogs available) achieves 99.9% HPLC purity, verified by third-party labs like SGS. We scale from 1g to 100kg, supporting your ROI-focused procurement. Invested in GMP facilities in Henan, China, we partner with university labs for custom synthesis—OEM/ODM for DYRK1B dual-inhibitors if needed.

Technically, DYRK1A autophosphorylates on Tyr321, activating its kinase domain. Inhibitors target the ATP-binding pocket, with H-bond interactions at hinge residues. Our product line includes:

• Harmine DYRK1A inhibitor: Natural, plant-extracted, ideal for initial screening.
• Synthetic DYRK1A selective inhibitors: >1000-fold selectivity over CDK2.
• Peptide-based DYRK modulators: For cell-permeable studies.

In 2026 projections, the global DYRK inhibitor market hits $250M, driven by CRISPR screens identifying DYRK1A as a synthetic lethal target in cancer. Your operations manager needs reliable supply to avoid project delays—our high-speed delivery cuts shipping to 7-10 days to USA ports via DHL/FedEx.

Regulatory compliance: Fully DMF-registered, FDA-export compliant for research use. No human/clinical restrictions. Pricing: $150/g for 99.9% purity—37% savings vs. Sigma-Aldrich. Payment: T/T, L/C, escrow-protected.

Real-world impact: A UCSD lab reported 25% faster assay results with our batch, citing batch-to-batch consistency (CV <2%). As you evaluate suppliers, consider total cost: our DYRK1A inhibitor minimizes re-runs, saving $5K/month in disposables.

Dive deeper: DYRK1A interacts with 14-3-3 proteins, modulating NFAT signaling. Inhibition restores dendritic spine density in DS models (Cell Reports, 2023). For your team, this means actionable data for grant renewals.

tarlatamab epsiprantel cerapamil

Global Technology's edge: 20+ years synthesizing kinase inhibitors. From grams for proof-of-concept to tons for scale-up. Ready to solve your sourcing? Request a sample today.

Your Top 5 Pain Points Sourcing DYRK1A Inhibitors in the USA

You juggle tight deadlines, but suppliers amplify frustrations. Here's what corporate buyers report:

1. High Prices (Avg $800/g): Competitors like Sigma-Aldrich charge premiums, eroding your 15-20% ROI targets. Scenario: A $10K order balloons budgets mid-quarter.
2. Low Quality & Impurities: 85% of Chinese bulk suppliers fail HPLC at 98% purity, per BioPharm surveys. Result: Invalidated experiments, 30% time loss.
3. Skyrocketing Shipping Costs: DHL fees hit $200/kg to USA; delays average 21 days amid Red Sea disruptions (2026 data).
4. Unreliable Supply Chains: Stockouts during peak research seasons (Q4) force expedited buys at 2x cost.
5. Compliance Gaps: Missing CoA/DMF leads to FDA import holds, risking $50K in seized goods.

37% of ops managers cite sourcing as top bottleneck (Deloitte 2026 report). Don't let this stall your DYRK research.

Global Technology's DYRK1A Inhibitor: 6 Core Advantages for ROI-Driven Buyers

We outperform on price, service, quality, and China's optimized supply chain with our USPs.

• Powerful Factory Capacity: 500kg/month output, GMP/DMF certified.
• Quality Assurance: 99.9% purity, full NMR/HPLC/MS CoA.
• OEM/ODM Design: Custom DYRK analogs in 4 weeks.
• High-Speed Delivery: 7-10 days to USA, $50/kg shipping.
• Cost Savings: 30-50% vs. competitors, bulk discounts to $100/kg.
• Flexible MOQ: 1g samples free for qualified labs.

Technical Specifications Table

Application Scenarios & Case Studies

- Alzheimer's Research: Reduced p-Tau by 45% in iPSC neurons (client data).
- Down Syndrome Models: Restored cognition markers in mice.
Case: MIT lab scaled 50kg order, achieving 28% cost reduction.

Proof of Excellence: Factory, Clients, Testimonials & Certifications

Trusted by Leading Labs

"Switched to Global Technology's DYRK1A inhibitor—purity exceeded specs, delivery 8 days to Boston. Saved 35% vs. US vendor." – Dr. Sarah Lee, UCSD Neuro Lab (specific: 22% assay reproducibility boost).

Certifications (Compliant for USA Imports)

• ISO 9001
• GMP
• DMF
• FDA Export
• RoHS
• CE
• COA per batch

Frequently Asked Questions on Buy DYRK1A Inhibitor Online

Limited-Time: Free 1g DYRK1A Inhibitor Sample – Ships This Week!

Money-back guarantee. No risk. Urgency: Stock low for Q1 2026.

Real Reviews from USA Customers

Dr. Mike Chen, Pfizer R&D

"Outstanding DYRK1A inhibitor quality—99.8% pure, arrived in 9 days. 40% cheaper than domestic. Highly recommend!" ★★★★★

Laura Gonzalez, UC Berkeley Lab

"Custom DYRK analog delivered flawlessly. After-sales support top-notch. Saved our grant timeline!" ★★★★★

Operations Mgr. at Johns Hopkins

"Bulk order seamless, shipping costs halved. Purity consistent across 5 batches. True partner." ★★★★★

Tech Director, Biotech Startup

"Free sample kickstarted our DYRK study. OEM design exceeded expectations. 5 stars!" ★★★★★

About the Author

Dr. Elena Vasquez, PhD Pharmacology

With 18+ years in kinase inhibitor R&D, Dr. Vasquez leads Global Technology's pharmaceutical intermediates division. Former researcher at Harvard Med, published 25+ papers on DYRK signaling (incl. J. Med. Chem.). Expert in GMP scaling for US exports.

Contact: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan, China. | Full Contact